| Literature DB >> 25915474 |
Ariadna Laguna1, Nicoletta Schintu2, André Nobre3, Alexandra Alvarsson2, Nikolaos Volakakis3, Jesper Kjaer Jacobsen3, Marta Gómez-Galán4, Elena Sopova4, Eliza Joodmardi3, Takashi Yoshitake5, Qiaolin Deng6, Jan Kehr5, Johan Ericson6, Per Svenningsson2, Oleg Shupliakov4, Thomas Perlmann7.
Abstract
The role of developmental transcription factors in maintenance of neuronal properties and in disease remains poorly understood. Lmx1a and Lmx1b are key transcription factors required for the early specification of ventral midbrain dopamine (mDA) neurons. Here we show that conditional ablation of Lmx1a and Lmx1b after mDA neuron specification resulted in abnormalities that show striking resemblance to early cellular abnormalities seen in Parkinson's disease. We found that Lmx1b was required for the normal execution of the autophagic-lysosomal pathway and for the integrity of dopaminergic nerve terminals and long-term mDA neuronal survival. Notably, human LMX1B expression was decreased in mDA neurons in brain tissue affected by Parkinson's disease. Thus, these results reveal a sustained and essential requirement of Lmx1b for the function of midbrain mDA neurons and suggest that its dysfunction is associated with Parkinson's disease pathogenesis.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25915474 DOI: 10.1038/nn.4004
Source DB: PubMed Journal: Nat Neurosci ISSN: 1097-6256 Impact factor: 24.884